FDA clears AI-powered second-read tool that catches missed prostate cancers on biopsy
Evidence stage: Later-Stage HumanRegulatory status: FDA Approved
The FDA granted 510(k) clearance -- a real FDA regulatory action for a diagnostic device, distinct from the drug-approval pathway most other records on this site describe -- to Ibex…
Primary source cited
Last reviewed